Pines Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.43M Buy
4,815
+62
+1% +$62.9K 1.43% 16
2025
Q4
$5.11M Buy
4,753
+102
+2% +$97.5K 1.65% 15
2025
Q3
$3.55M Buy
4,651
+281
+6% +$209K 1.2% 17
2025
Q2
$3.41M Buy
4,370
+291
+7% +$226K 1.21% 16
2025
Q1
$2.96M Buy
4,079
+530
+15% +$441K 1.37% 16
2024
Q4
$2.84M Buy
+3,549
New +$2.94M 1.24% 18

Other funds holding LLY

Pines Wealth Management's LLY Position: Q1 2026 in Review

Pines Wealth Management increased its Eli Lilly (LLY) stake by 1.3% in Q1 2026, buying an estimated $62.9K and bringing the position to 4,815 shares worth $4.43M. The position accounts for 1.43% of the portfolio, ranked #16.

Pines Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.11M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pines Wealth Management held 4,815 shares of Eli Lilly worth $4.43M as of Q1 2026.
  • Pines Wealth Management bought 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
  • Eli Lilly made up 1.43% of Pines Wealth Management's portfolio in Q1 2026, its #16 holding.
  • Pines Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Pines Wealth Management's Eli Lilly position peaked at $5.11M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pines Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.